Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non–small cell lung, prostate, and breast cancers

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, September 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 8 X users
facebook: 1 Facebook page

reddit: 1 Redditor

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 10 X posts from 8 X users, with an upper bound of 12,053 followers.

RT @EChrisDee: 📜 In @JNCI_Now led by @AlexGoglia & Mohammed Alshalalfa, we explored FOXA1 alterations in 87k pts, w implications in #lung ,…

RT @alexgoglia: Our paper is now online in @JNCI_Now! We looked at genomic alterations of the transcription factor FOXA1 in a large pan-can…

RT @EChrisDee: 📜 In @JNCI_Now led by @AlexGoglia & Mohammed Alshalalfa, we explored FOXA1 alterations in 87k pts, w implications in #lung ,…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.